tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Schwartz, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).
Analyst Alex Schwartz, currently employed carries an average stock price target met ratio of 33.33% that have a potential upside of 4.3% achieved within 15 days. Previously, Alex Schwartz worked at STIFEL.
Alex Schwartz’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANAB, AnaptysBio at 21-Feb-2024.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/5/2018. The price target of $15 was fulfilled within 4 days with a profit of $2.55 (14.53%) receiving and performance score of 36.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$16
$13.88 (654.72%)
$16
13 days ago
(08-Nov-2024)
0/10 (0%)
$13.72 (601.75%)
Buy
$6
$3.88 (183.02%)
$8
3 months 8 days ago
(13-Aug-2024)
0/9 (0%)
$4.2 (233.33%)
Hold
$2.5
$0.38 (17.92%)
5 months 1 days ago
(20-Jun-2024)
2/4 (50%)
$0.21 (9.17%)
14
Hold
$9
1 years 1 days ago
(20-Nov-2023)
4/8 (50%)
$2.84 (46.10%)
92
Hold
$3
$0.88 (41.51%)
1 years 8 months 1 days ago
(20-Mar-2023)
4/7 (57.14%)
$1.46 (94.81%)
80
What Year was the first public recommendation made by Alex Schwartz?
